missing translation for 'onlineSavingsMsg'
Learn More
Learn More
C4 alpha chain/C4b/C4d Rabbit anti-Human, Polyclonal, Proteintech
Rabbit Polyclonal Antibody
Marque: Proteintech 22233-1-AP-150UL
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
This antibody raised against 1017-1336aa of human C4-A protein can recognize C4 precursor, C4 alpha chain, C4b, and C4d.
This gene encodes the acidic form of complement factor 4, part of the classical activation pathway. The protein is expressed as a single chain precursor which is proteolytically cleaved into a trimer of alpha, beta, and gamma chains prior to secretion. The trimer provides a surface for interaction between the antigen-antibody complex and other complement components. The alpha chain may be cleaved to release C4 anaphylatoxin, a mediator of local inflammation. Deficiency of this protein is associated with systemic lupus erythematosus and type I diabetes mellitus. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. Varying haplotypes of this gene cluster exist, such that individuals may have 1, 2, or 3 copies of this gene.Spécification
C4 alpha chain/C4b/C4d | |
Polyclonal | |
Unconjugated | |
C4A | |
Acidic complement C4, C4, C4A, C4A2, C4A3, C4A4, C4A6, C4S, CO4, Complement C4 A, CPAMD2, RG | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
720 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot | |
0.25 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 | |
P0C0L4 | |
C4A | |
C4 alpha chain/C4b/C4d Fusion Protein Ag17583 | |
150 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Suggestions de produits
Clients qui ont consulté cet article ont également consulté
Viewing 1-5 of 12
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
C4 alpha chain/C4b/C4d Rabbit anti-Human, Polyclonal, Proteintech > 150 μL; Unconjugated
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu